Request for Covid-19 Impact Assessment of this Report
The United States Glatiramer market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Glatiramer market, reaching US$ million by the year 2028. As for the Europe Glatiramer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Glatiramer players cover Teva, NATCO Pharma, Mylan, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Glatiramer market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Brand Medicine
Generic Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Teva
NATCO Pharma
Mylan
Novartis
HYBIO
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glatiramer Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Glatiramer by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Glatiramer by Country/Region, 2017, 2022 & 2028
2.2 Glatiramer Segment by Type
2.2.1 Brand Medicine
2.2.2 Generic Drug
2.3 Glatiramer Sales by Type
2.3.1 Global Glatiramer Sales Market Share by Type (2017-2022)
2.3.2 Global Glatiramer Revenue and Market Share by Type (2017-2022)
2.3.3 Global Glatiramer Sale Price by Type (2017-2022)
2.4 Glatiramer Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Glatiramer Sales by Application
2.5.1 Global Glatiramer Sale Market Share by Application (2017-2022)
2.5.2 Global Glatiramer Revenue and Market Share by Application (2017-2022)
2.5.3 Global Glatiramer Sale Price by Application (2017-2022)
3 Global Glatiramer by Company
3.1 Global Glatiramer Breakdown Data by Company
3.1.1 Global Glatiramer Annual Sales by Company (2020-2022)
3.1.2 Global Glatiramer Sales Market Share by Company (2020-2022)
3.2 Global Glatiramer Annual Revenue by Company (2020-2022)
3.2.1 Global Glatiramer Revenue by Company (2020-2022)
3.2.2 Global Glatiramer Revenue Market Share by Company (2020-2022)
3.3 Global Glatiramer Sale Price by Company
3.4 Key Manufacturers Glatiramer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glatiramer Product Location Distribution
3.4.2 Players Glatiramer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Glatiramer by Geographic Region
4.1 World Historic Glatiramer Market Size by Geographic Region (2017-2022)
4.1.1 Global Glatiramer Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Glatiramer Annual Revenue by Geographic Region
4.2 World Historic Glatiramer Market Size by Country/Region (2017-2022)
4.2.1 Global Glatiramer Annual Sales by Country/Region (2017-2022)
4.2.2 Global Glatiramer Annual Revenue by Country/Region
4.3 Americas Glatiramer Sales Growth
4.4 APAC Glatiramer Sales Growth
4.5 Europe Glatiramer Sales Growth
4.6 Middle East & Africa Glatiramer Sales Growth
5 Americas
5.1 Americas Glatiramer Sales by Country
5.1.1 Americas Glatiramer Sales by Country (2017-2022)
5.1.2 Americas Glatiramer Revenue by Country (2017-2022)
5.2 Americas Glatiramer Sales by Type
5.3 Americas Glatiramer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glatiramer Sales by Region
6.1.1 APAC Glatiramer Sales by Region (2017-2022)
6.1.2 APAC Glatiramer Revenue by Region (2017-2022)
6.2 APAC Glatiramer Sales by Type
6.3 APAC Glatiramer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glatiramer by Country
7.1.1 Europe Glatiramer Sales by Country (2017-2022)
7.1.2 Europe Glatiramer Revenue by Country (2017-2022)
7.2 Europe Glatiramer Sales by Type
7.3 Europe Glatiramer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glatiramer by Country
8.1.1 Middle East & Africa Glatiramer Sales by Country (2017-2022)
8.1.2 Middle East & Africa Glatiramer Revenue by Country (2017-2022)
8.2 Middle East & Africa Glatiramer Sales by Type
8.3 Middle East & Africa Glatiramer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glatiramer
10.3 Manufacturing Process Analysis of Glatiramer
10.4 Industry Chain Structure of Glatiramer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glatiramer Distributors
11.3 Glatiramer Customer
12 World Forecast Review for Glatiramer by Geographic Region
12.1 Global Glatiramer Market Size Forecast by Region
12.1.1 Global Glatiramer Forecast by Region (2023-2028)
12.1.2 Global Glatiramer Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glatiramer Forecast by Type
12.7 Global Glatiramer Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Glatiramer Product Offered
13.1.3 Teva Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 NATCO Pharma
13.2.1 NATCO Pharma Company Information
13.2.2 NATCO Pharma Glatiramer Product Offered
13.2.3 NATCO Pharma Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 NATCO Pharma Main Business Overview
13.2.5 NATCO Pharma Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Glatiramer Product Offered
13.3.3 Mylan Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Glatiramer Product Offered
13.4.3 Novartis Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 HYBIO
13.5.1 HYBIO Company Information
13.5.2 HYBIO Glatiramer Product Offered
13.5.3 HYBIO Glatiramer Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 HYBIO Main Business Overview
13.5.5 HYBIO Latest Developments
14 Research Findings and Conclusion
Table 1. Glatiramer Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Glatiramer Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Brand Medicine
Table 4. Major Players of Generic Drug
Table 5. Global Glatiramer Sales by Type (2017-2022) & (K Units)
Table 6. Global Glatiramer Sales Market Share by Type (2017-2022)
Table 7. Global Glatiramer Revenue by Type (2017-2022) & ($ million)
Table 8. Global Glatiramer Revenue Market Share by Type (2017-2022)
Table 9. Global Glatiramer Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Glatiramer Sales by Application (2017-2022) & (K Units)
Table 11. Global Glatiramer Sales Market Share by Application (2017-2022)
Table 12. Global Glatiramer Revenue by Application (2017-2022)
Table 13. Global Glatiramer Revenue Market Share by Application (2017-2022)
Table 14. Global Glatiramer Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Glatiramer Sales by Company (2020-2022) & (K Units)
Table 16. Global Glatiramer Sales Market Share by Company (2020-2022)
Table 17. Global Glatiramer Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Glatiramer Revenue Market Share by Company (2020-2022)
Table 19. Global Glatiramer Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Glatiramer Producing Area Distribution and Sales Area
Table 21. Players Glatiramer Products Offered
Table 22. Glatiramer Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glatiramer Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Glatiramer Sales Market Share Geographic Region (2017-2022)
Table 27. Global Glatiramer Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Glatiramer Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Glatiramer Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Glatiramer Sales Market Share by Country/Region (2017-2022)
Table 31. Global Glatiramer Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Glatiramer Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Glatiramer Sales by Country (2017-2022) & (K Units)
Table 34. Americas Glatiramer Sales Market Share by Country (2017-2022)
Table 35. Americas Glatiramer Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Glatiramer Revenue Market Share by Country (2017-2022)
Table 37. Americas Glatiramer Sales by Type (2017-2022) & (K Units)
Table 38. Americas Glatiramer Sales Market Share by Type (2017-2022)
Table 39. Americas Glatiramer Sales by Application (2017-2022) & (K Units)
Table 40. Americas Glatiramer Sales Market Share by Application (2017-2022)
Table 41. APAC Glatiramer Sales by Region (2017-2022) & (K Units)
Table 42. APAC Glatiramer Sales Market Share by Region (2017-2022)
Table 43. APAC Glatiramer Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Glatiramer Revenue Market Share by Region (2017-2022)
Table 45. APAC Glatiramer Sales by Type (2017-2022) & (K Units)
Table 46. APAC Glatiramer Sales Market Share by Type (2017-2022)
Table 47. APAC Glatiramer Sales by Application (2017-2022) & (K Units)
Table 48. APAC Glatiramer Sales Market Share by Application (2017-2022)
Table 49. Europe Glatiramer Sales by Country (2017-2022) & (K Units)
Table 50. Europe Glatiramer Sales Market Share by Country (2017-2022)
Table 51. Europe Glatiramer Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Glatiramer Revenue Market Share by Country (2017-2022)
Table 53. Europe Glatiramer Sales by Type (2017-2022) & (K Units)
Table 54. Europe Glatiramer Sales Market Share by Type (2017-2022)
Table 55. Europe Glatiramer Sales by Application (2017-2022) & (K Units)
Table 56. Europe Glatiramer Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Glatiramer Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Glatiramer Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Glatiramer Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Glatiramer Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Glatiramer Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Glatiramer Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Glatiramer Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Glatiramer Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Glatiramer
Table 66. Key Market Challenges & Risks of Glatiramer
Table 67. Key Industry Trends of Glatiramer
Table 68. Glatiramer Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Glatiramer Distributors List
Table 71. Glatiramer Customer List
Table 72. Global Glatiramer Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Glatiramer Sales Market Forecast by Region
Table 74. Global Glatiramer Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Glatiramer Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Glatiramer Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Glatiramer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Glatiramer Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Glatiramer Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Glatiramer Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Glatiramer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Glatiramer Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Glatiramer Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Glatiramer Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Glatiramer Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Glatiramer Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Glatiramer Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Glatiramer Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Glatiramer Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Glatiramer Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Glatiramer Revenue Market Share Forecast by Application (2023-2028)
Table 92. Teva Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Glatiramer Product Offered
Table 94. Teva Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Teva Main Business
Table 96. Teva Latest Developments
Table 97. NATCO Pharma Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors
Table 98. NATCO Pharma Glatiramer Product Offered
Table 99. NATCO Pharma Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. NATCO Pharma Main Business
Table 101. NATCO Pharma Latest Developments
Table 102. Mylan Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors
Table 103. Mylan Glatiramer Product Offered
Table 104. Mylan Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Mylan Main Business
Table 106. Mylan Latest Developments
Table 107. Novartis Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis Glatiramer Product Offered
Table 109. Novartis Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Novartis Main Business
Table 111. Novartis Latest Developments
Table 112. HYBIO Basic Information, Glatiramer Manufacturing Base, Sales Area and Its Competitors
Table 113. HYBIO Glatiramer Product Offered
Table 114. HYBIO Glatiramer Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. HYBIO Main Business
Table 116. HYBIO Latest Developments
List of Figures
Figure 1. Picture of Glatiramer
Figure 2. Glatiramer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glatiramer Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Glatiramer Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Glatiramer Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Brand Medicine
Figure 10. Product Picture of Generic Drug
Figure 11. Global Glatiramer Sales Market Share by Type in 2021
Figure 12. Global Glatiramer Revenue Market Share by Type (2017-2022)
Figure 13. Glatiramer Consumed in Hospital
Figure 14. Global Glatiramer Market: Hospital (2017-2022) & (K Units)
Figure 15. Glatiramer Consumed in Pharmacy
Figure 16. Global Glatiramer Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Glatiramer Consumed in Other
Figure 18. Global Glatiramer Market: Other (2017-2022) & (K Units)
Figure 19. Global Glatiramer Sales Market Share by Application (2017-2022)
Figure 20. Global Glatiramer Revenue Market Share by Application in 2021
Figure 21. Glatiramer Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Glatiramer Revenue Market Share by Company in 2021
Figure 23. Global Glatiramer Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Glatiramer Revenue Market Share by Geographic Region in 2021
Figure 25. Global Glatiramer Sales Market Share by Region (2017-2022)
Figure 26. Global Glatiramer Revenue Market Share by Country/Region in 2021
Figure 27. Americas Glatiramer Sales 2017-2022 (K Units)
Figure 28. Americas Glatiramer Revenue 2017-2022 ($ Millions)
Figure 29. APAC Glatiramer Sales 2017-2022 (K Units)
Figure 30. APAC Glatiramer Revenue 2017-2022 ($ Millions)
Figure 31. Europe Glatiramer Sales 2017-2022 (K Units)
Figure 32. Europe Glatiramer Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Glatiramer Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Glatiramer Revenue 2017-2022 ($ Millions)
Figure 35. Americas Glatiramer Sales Market Share by Country in 2021
Figure 36. Americas Glatiramer Revenue Market Share by Country in 2021
Figure 37. United States Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Glatiramer Sales Market Share by Region in 2021
Figure 42. APAC Glatiramer Revenue Market Share by Regions in 2021
Figure 43. China Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Glatiramer Sales Market Share by Country in 2021
Figure 50. Europe Glatiramer Revenue Market Share by Country in 2021
Figure 51. Germany Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Glatiramer Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Glatiramer Revenue Market Share by Country in 2021
Figure 58. Egypt Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Glatiramer Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Glatiramer in 2021
Figure 64. Manufacturing Process Analysis of Glatiramer
Figure 65. Industry Chain Structure of Glatiramer
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...